| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 25 |
| 1 | LETROZOLE | 14 |
| 2 | METFORMIN | 11 |
| 3 | METFORMIN ER 500 MG | 10 |
| 4 | METFORMIN ER 750 MG | 10 |
| 5 | CALCIUM | 9 |
| 6 | ANASTROZOLE | 7 |
| 7 | ANASTROZOLE TABLETS | 7 |
| 8 | FULVESTRANT | 7 |
| 9 | LANSOPRAZOLE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 3 | 0.0056 |
| 1 | ERGOTAMINE TARTRATE AND CAFFEINE | 1 | 0.0037 |
| 2 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 4 | 0.0037 |
| 3 | RIBOCICLIB | 25 | 0.0008 |
| 4 | ANASTROZOLE TABLETS | 7 | 0.0003 |
| 5 | LETROZOLE | 14 | 0.0002 |
| 6 | FULVESTRANT | 7 | 0.0002 |
| 7 | ERGOCALCIFEROL | 6 | 0.0002 |
| 8 | ANASTROZOLE | 7 | 0.0002 |
| 9 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 15 |
| 1 | Proton Pump Inhibitor [EPC] | 10 |
| 2 | Calcium [EPC] | 9 |
| 3 | Corticosteroid [EPC] | 7 |
| 4 | Estrogen Receptor Antagonist [EPC] | 7 |
| 5 | Opioid Agonist [EPC] | 6 |
| 6 | Provitamin D2 Compound [EPC] | 6 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 6 |
| 8 | Atypical Antipsychotic [EPC] | 5 |
| 9 | Benzodiazepine [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 3 | 0.0056 |
| 1 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 2 | Estrogen Receptor Antagonist [EPC] | 7 | 0.0002 |
| 3 | Aromatase Inhibitor [EPC] | 15 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Calcium [EPC] | 9 | 0.0001 |
| 6 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 6 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 2 | 0.0000 |